Gilead Sciences will partner with Google Parent Alphabet’s Verily Life Sciences over the next three years, applying Verily’s Immunoscape platform to better understand the immunological basis of three common diseases.
Researchers have identified a protein critical for the aggressiveness of T-cell leukaemia, a subtype of leukaemia that afflicts children and adults.
An FDA-approved drug originally designed to treat cancer may be an unlikely potential ally in the global fight against tuberculosis, a new study suggests.
Forget about the double helix – now, researchers have identified the existence of a new DNA structure that could play a crucial role in how DNA is expressed.
BD Bioscience today launched a new cloud-based system called ‘BD Synapsys Microbiology Informatics Solution’ to facilitate faster diagnostic results and improve infectious disease management.
A new study documents, for the first time, how the ability of bacteria to swap genetic material with each other can directly affect the emergence and spread of globally important infectious diseases.
General Electric aims to build on its existing expertise in biotech manufacturing by delivering a “factory-in-a-box” service specifically for viral vector-based medicine.
Researchers have discovered a way to greatly improve the accuracy of gene-editing technology by replacing the natural guide molecule it uses with a synthetic one called a bridged nucleic acid, or BNA.
A new cancer cell-based assay could help doctors diagnose cancer, better monitor the disease, and take a step closer to customised treatment for individual patients.